Oxomemazine is a phenothiazine-derived antihistamine with notable anticholinergic and sedative properties, mainly used for the treatment of allergic symptoms, pruritis, and sometimes cough. It functions as a H1-antihistamine, blocking the pharmacological activity of histamine at these receptors, and is sometimes formulated in combination with guaifenesin as an over-the-counter cough remedy in certain countries (but not FDA-approved in the United States). Its therapeutic use is listed as antihistamines. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dysedon, Doxergan and Imakol. Its PubChem CID is 19396.
Oxomemazine
| CAS No | 3689-50-7 |
|---|---|
| Molecular Formula | C18H22N2O2S |
| Molecular Weight | 330.4 g/mol |
| Synonyms | 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oxomemazine is a phenothiazine-derived antihistamine with notable anticholinergic and sedative properties, mainly used for the treatment of allergic symptoms, pruritis, and sometimes cough.
The listed CAS number is 3689-50-7.
The listed molecular formula is C18H22N2O2S.
The listed molecular weight is 330.4 g/mol.
3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine.
The source lists Dysedon, Doxergan and Imakol.